Surgical management of pancreatic cancer - Pancreaticoduodenectomy

Seminars in Oncology

Volumn 42, Issue 1, 2015, Pages 98-109

  Donahue, Timothy R ^a   Reber, Howard A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; ARTERIAL RESECTION; ARTICLE; BILIARY TRACT DRAINAGE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; FINE NEEDLE ASPIRATION BIOPSY; HISTOPATHOLOGY; HUMAN; LAPAROSCOPY; MORBIDITY; OUTCOME ASSESSMENT; PANCREAS CANCER; PANCREATICODUODENECTOMY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; VASCULAR SURGERY; VENOUS RESECTION; CARCINOMA, PANCREATIC DUCTAL; DISEASE MANAGEMENT; MORTALITY; PANCREAS; PANCREAS RESECTION; PANCREATIC NEOPLASMS; PATHOLOGY; TREATMENT OUTCOME; VASCULARIZATION;

CARCINOMA, PANCREATIC DUCTAL; DISEASE MANAGEMENT; HUMANS; NEOPLASM STAGING; PANCREAS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; TREATMENT OUTCOME;

EID: 84923507289     PISSN: 00937754     EISSN: 15328708     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2014.12.009     Document Type: Review

References (59)

1. K.K. Kazanjian, O.J. Hines, J.P. Duffy, D.Y. Yoon, G. Cortina, and H.A. Reber Improved survival following pancreaticoduodenectomy to treat adenocarcinoma of the pancreas: the influence of operative blood loss Arch Surg 143 12 2008 1166 1171
2. H. Oettle, P. Neuhaus, A. Hochhaus, J.T. Hartmann, K. Gellert, and K. Ridwelski Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial JAMA 310 14 2013 1473 1481
3. K.A. Bickenbach, M. Gonen, and L.H. Tang Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease Ann Surg Oncol 19 5 2012 1663 1669
4. M.H. Katz, J.B. Fleming, and P. Bhosale Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators Cancer 118 23 2012 5749 5756
5. B.E. Kadera, D.B. Sunjaya, and W.H. Isacoff Locally advanced pancreatic cancer: association between prolonged preoperative treatment and lymph-node negativity and overall survival JAMA Surg 149 2 2014 145 153
6. T.R. Donahue, W.H. Isacoff, and O.J. Hines Downstaging chemotherapy and alteration in the classic computed tomography/magnetic resonance imaging signs of vascular involvement in patients with pancreaticobiliary malignant tumors: influence on patient selection for surgery Arch Surg 146 7 2011 836 843
7. M.H. Katz, P.W. Pisters, and D.B. Evans Borderline resectable pancreatic cancer: the importance of this emerging stage of disease J Am Coll Surg 206 5 2008 833 846 discussion 46-8
8. M.A. Tempero, J.P. Arnoletti, and S. Behrman Pancreatic adenocarcinoma J Natl Compr Canc Netw 8 9 2010 972 1017
9. M.A. Tempero, J.P. Arnoletti, and S.W. Behrman Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines J Natl Compr Canc Netw 10 6 2012 703 713
10. P.J. Campbell, S. Yachida, and L.J. Mudie The patterns and dynamics of genomic instability in metastatic pancreatic cancer Nature 467 7319 2010 1109 1113
11. S. Yachida, S. Jones, and I. Bozic Distant metastasis occurs late during the genetic evolution of pancreatic cancer Nature 467 7319 2010 1114 1117
12. N.A. Ahmad, J.D. Lewis, E.S. Siegelman, E.F. Rosato, G.G. Ginsberg, and M.L. Kochman Role of endoscopic ultrasound and magnetic resonance imaging in the preoperative staging of pancreatic adenocarcinoma Am J Gastroenterol 95 8 2000 1926 1931
13. J. Dewitt, B.M. Devereaux, G.A. Lehman, S. Sherman, and T.F. Imperiale Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review Clin Gastroenterol Hepatol 4 6 2006 717 725 quiz 664
14. J. DeWitt, B. Devereaux, and M. Chriswell Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer Ann Intern Med 141 10 2004 753 763
15. N.A. van der Gaag, E.A. Rauws, and C.H. van Eijck Preoperative biliary drainage for cancer of the head of the pancreas N Engl J Med 362 2 2010 129 137
16. M.J. Hewitt, M.J. McPhail, L. Possamai, A. Dhar, P. Vlavianos, K.J. Monahan, and F.N.A. EUS-guided for diagnosis of solid pancreatic neoplasms: a meta-analysis Gastrointest Endosc 75 2 2012 319 331
17. G. Chen, S. Liu, Y. Zhao, M. Dai, and T. Zhang Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for pancreatic cancer: a meta-analysis Pancreatology 13 3 2013 298 304
18. S. Hebert-Magee, S. Bae, and S. Varadarajulu The presence of a cytopathologist increases the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration cytology for pancreatic adenocarcinoma: a meta-analysis Cytopathology 24 3 2013 159 171
19. M.F. Madhoun, S.B. Wani, and A. Rastogi The diagnostic accuracy of 22-gauge and 25-gauge needles in endoscopic ultrasound-guided fine needle aspiration of solid pancreatic lesions: a meta-analysis Endoscopy 45 2 2013 86 92
20. S.R. Puli, M.L. Bechtold, J.L. Buxbaum, and M.A. Eloubeidi How good is endoscopic ultrasound-guided fine-needle aspiration in diagnosing the correct etiology for a solid pancreatic mass?: A meta-analysis and systematic review Pancreas 42 1 2013 20 26
21. J.G. Fortner, D.S. Klimstra, R.T. Senie, and B.J. Maclean Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy Ann Surg 223 2 1996 147 153
22. J.G. Fortner Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Tumor staging and results Ann Surg 199 4 1984 418 425
23. A. Stojadinovic, A. Brooks, A. Hoos, D.P. Jaques, K.C. Conlon, and M.F. Brennan An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma J Am Coll Surg 196 6 2003 954 964
24. P. Pessaux, D. Varma, and J.P. Arnaud Pancreaticoduodenectomy: superior mesenteric artery first approach J Gastrointest Surg 10 4 2006 607 611
25. R.F. Payne, and J.A. Pain Duct-to-mucosa pancreaticogastrostomy is a safe anastomosis following pancreaticoduodenectomy Br J Surg 93 1 2006 73 77
26. J.M. Winter, J.L. Cameron, and K.A. Campbell Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial J Gastrointest Surg 10 9 2006 1280 1290 discussion 90
27. R.T. Poon, S.T. Fan, and C.M. Lo External drainage of pancreatic duct with a stent to reduce leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy: a prospective randomized trial Ann Surg 246 3 2007 425 433 discussion 33-5
28. F. Motoi, S. Egawa, T. Rikiyama, Y. Katayose, and M. Unno Randomized clinical trial of external stent drainage of the pancreatic duct to reduce postoperative pancreatic fistula after pancreaticojejunostomy Br J Surg 99 4 2012 524 531
29. T. Kuroki, Y. Tajima, A. Kitasato, T. Adachi, and T. Kanematsu Stenting versus non-stenting in pancreaticojejunostomy: a prospective study limited to a normal pancreas without fibrosis sorted by using dynamic MRI Pancreas 40 1 2011 25 29
30. P. Pessaux, A. Sauvanet, and C. Mariette External pancreatic duct stent decreases pancreatic fistula rate after pancreaticoduodenectomy: prospective multicenter randomized trial Ann Surg 253 5 2011 879 885
31. C.J. Yeo, J.L. Cameron, and T.A. Sohn Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes Ann Surg 226 3 1997 248 257
32. M. Trede, G. Schwall, and H.D. Saeger Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality Ann Surg 211 4 1990 447 458
33. C.A. Pellegrini, C.F. Heck, S. Raper, and L.W. Way An analysis of the reduced morbidity and mortality rates after pancreaticoduodenectomy Arch Surg 124 7 1989 778 781
34. D.W. Crist, J.V. Sitzmann, and J.L. Cameron Improved hospital morbidity, mortality, and survival after the Whipple procedure Ann Surg 206 3 1987 358 365
35. P.J. Kneuertz, H.A. Pitt, and K.Y. Bilimoria Risk of morbidity and mortality following hepato-pancreato-biliary surgery J Gastrointest Surg 16 9 2012 1727 1735
36. L.W. Traverso, and Y. Hashimoto Delayed gastric emptying: the state of the highest level of evidence J Hepatobiliary Pancreat Surg 15 3 2008 262 269
37. J.J. Cullen, M.G. Sarr, and D.M. Ilstrup Pancreatic anastomotic leak after pancreaticoduodenectomy: incidence, significance, and management Am J Surg 168 4 1994 295 298
38. C. Bassi, C. Dervenis, and G. Butturini Postoperative pancreatic fistula: an international study group (ISGPF) definition Surgery 138 1 2005 8 13
39. K.K. Kazanjian, O.J. Hines, G. Eibl, and H.A. Reber Management of pancreatic fistulas after pancreaticoduodenectomy: results in 437 consecutive patients Arch Surg 140 9 2005 849 854 discussion 54-6
40. S.H. Teh, B.S. Diggs, C.W. Deveney, and B.C. Sheppard Patient and hospital characteristics on the variance of perioperative outcomes for pancreatic resection in the United States: a plea for outcome-based and not volume-based referral guidelines Arch Surg 144 8 2009 713 721
41. R.W. Eppsteiner, N.G. Csikesz, J.T. McPhee, J.F. Tseng, and S.A. Shah Surgeon volume impacts hospital mortality for pancreatic resection Ann Surg 249 4 2009 635 640
42. J.D. Birkmeyer, Y. Sun, S.L. Wong, and T.A. Stukel Hospital volume and late survival after cancer surgery Ann Surg 245 5 2007 777 783
43. D.B. Evans, M.B. Farnell, K.D. Lillemoe, C. Vollmer Jr, S.M. Strasberg, and R.D. Schulick Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement Ann Surg Oncol 16 7 2009 1736 1744
44. M.H. Katz, J.E. Lee, P.W. Pisters, R. Skoracki, E. Tamm, and J.B. Fleming Retroperitoneal dissection in patients with borderline resectable pancreatic cancer: operative principles and techniques J Am Coll Surg 215 2 2012 e11-8
45. J.F. Tseng, C.P. Raut, and J.E. Lee Pancreaticoduodenectomy with vascular resection: margin status and survival duration J Gastrointest Surg 8 8 2004 935 949
46. C.P. Raut, J.F. Tseng, and C.C. Sun Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma Ann Surg 246 1 2007 52 60
47. R.C. Martin 2nd, C.R. Scoggins, V. Egnatashvili, C.A. Staley, K.M. McMasters, and D.A. Kooby Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes Arch Surg 144 2 2009 154 159
48. G. Ramacciato, P. Mercantini, and N. Petrucciani Does portal-superior mesenteric vein invasion still indicate irresectability for pancreatic carcinoma? Ann Surg Oncol 16 4 2009 817 825
49. S.D. Leach, J.E. Lee, and C. Charnsangavej Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head Br J Surg 85 5 1998 611 617
50. G.M. Fuhrman, S.D. Leach, and C.A. Staley Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group Ann Surg 223 2 1996 154 162
51. Y. Murakami, K. Uemura, and T. Sudo Benefit of portal or superior mesenteric vein resection with adjuvant chemotherapy for patients with pancreatic head carcinoma J Surg Oncol 107 4 2013 414 421
52. N. Mollberg, N.N. Rahbari, and M. Koch Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis Ann Surg 254 6 2011 882 893
53. W.F. Regine, K.A. Winter, and R. Abrams Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial Ann Surg Oncol 18 5 2011 1319 1326
54. A.C. Berger, K. Winter, and J.P. Hoffman Five year results of US intergroup/RTOG 9704 with postoperative CA 19-9
55. J.L. Cameron, D.W. Crist, and J.V. Sitzmann Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer Am J Surg 161 1 1991 120 124
56. J. Hernandez, J. Mullinax, and W. Clark Survival after pancreaticoduodenectomy is not improved by extending resections to achieve negative margins Ann Surg 250 1 2009 76 80
57. M. Dillhoff, R. Yates, and K. Wall Intraoperative assessment of pancreatic neck margin at the time of pancreaticoduodenectomy increases likelihood of margin-negative resection in patients with pancreatic cancer J Gastrointest Surg 13 5 2009 825 830
58. I.T. Konstantinidis, A.L. Warshaw, and J.N. Allen Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection? Ann Surg 257 4 2013 731 736
59. J. Fatima, T. Schnelldorfer, and J. Barton Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival Arch Surg 145 2 2010 167 172